Control of intracellular calcium in the presence of nitric oxide donors in isolated skeletal muscle fibres from mouse

被引:33
作者
Pouvreau, S [1 ]
Allard, B [1 ]
Berthier, C [1 ]
Jacquemond, V [1 ]
机构
[1] Univ Lyon 1, UMR CNRS 5123, F-69622 Villeurbanne, France
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2004年 / 560卷 / 03期
关键词
D O I
10.1113/jphysiol.2004.072397
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In skeletal muscle, nitric oxide (NO) is commonly referred to as a modulator of the activity of the ryanodine receptor (RyR) calcium release channel. However the reported effects of NO on isolated sarcoplasmic reticulum (SR) preparations and single ryanodine receptor (RyR) activity are diverse, and how NO affects SR calcium release and intracellular calcium homeostasis under physiological conditions remains poorly documented and hardly predictable. Here, we studied the effects of NO donors on membrane current and intracellular [Ca2+] in single skeletal muscle fibres from mouse, under voltage-clamp conditions. When fibres were chronically exposed to millimolar levels of sodium nitroprusside (SNP) and challenged by short membrane depolarizations, there was a progressive increase in the resting [Ca2+] level. This effect was use-dependent with the slope of rise in resting [Ca2+] being increased two-fold when the depolarizing pulse level was raised from -20 to +10 mV. Analysis of the decay of the [Ca2+] transients suggested that cytoplasmic Ca2+ removal processes were largely unaffected by the presence of SNP. Also the functional properties of the dihydropyridine receptor were very similar under control conditions and in the presence of SNP. The resting [Ca2+] elevation due to SNP was accompanied by a depression of the peak calcium release elicited by pulses to +10 mV. The effects of SNP could be reproduced by the chemically distinct NO donor NOC-12. They could be reversed upon exposure of the fibres to the thiol reducing agent dithiothreitol. Results suggest that large levels of NO produce a redox-sensitive continuous leak of Ca2+ from the SR, through a limited number of release channels that do not close once they are activated by membrane depolarization. This SR Ca2+ leak and the resulting increase in resting [Ca2+] may be important in mediating the effects of excess NO on voltage-activated calcium release.
引用
收藏
页码:779 / 794
页数:16
相关论文
共 38 条
[31]   Physiology of nitric oxide in skeletal muscle [J].
Stamler, JS ;
Meissner, G .
PHYSIOLOGICAL REVIEWS, 2001, 81 (01) :209-237
[32]   Nitric oxide activates skeletal and cardiac ryanodine receptors [J].
Stoyanovsky, D ;
Murphy, T ;
Anno, PR ;
Kim, YM ;
Salama, G .
CELL CALCIUM, 1997, 21 (01) :19-29
[33]   Activation and inhibition of purified skeletal muscle calcium release channel by NO donors in single channel current recordings [J].
Suko, J ;
Drobny, H ;
Hellmann, G .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1999, 1451 (2-3) :271-287
[34]   Nitric oxide, NOC-12, and S-nitrosoglutathione modulate the skeletal muscle calcium release channel/ryanodine receptor by different mechanisms -: An allosteric function for O2 in S-nitrosylation of the channel [J].
Sun, JH ;
Xu, L ;
Eu, JP ;
Stamler, JS ;
Meissner, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (10) :8184-8189
[35]   Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO [J].
Sun, JH ;
Xin, CL ;
Eu, JP ;
Stamler, JS ;
Meissner, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11158-11162
[36]   Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity [J].
Sunada, Y ;
Ohi, H ;
Hase, A ;
Ohi, H ;
Hosono, T ;
Arata, S ;
Higuchi, S ;
Matsumura, K ;
Shimizu, T .
HUMAN MOLECULAR GENETICS, 2001, 10 (03) :173-178
[37]   Deterministic inactivation of calcium release channels in mammalian skeletal muscle [J].
Szentesi, P ;
Kovács, L ;
Csernoch, L .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 528 (03) :447-456
[38]   Nitric oxide in renal cortex and medulla - An in vivo microdialysis study [J].
Zou, AP ;
Cowley, AW .
HYPERTENSION, 1997, 29 (01) :194-198